Literature DB >> 5016509

Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.

R H Lester, R C Elston, J B Graham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5016509      PMCID： PMC1762206     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  11 in total

1.  BRAIN SEROTONIN IN EXPERIMENTAL TYROSINOSIS.

Authors:  D Y HSIA; P JUSTICE; J L BERMAN; Y BRENCHLEY
Journal:  Nature       Date:  1964-05-02       Impact factor: 49.962

2.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

3.  Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state.

Authors:  J B GRAHAM; E M BARROW; C HOUGIE
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

4.  The frequency distribution of the product-moment correlation coefficient in random samples of any size drawn from non-normal universes.

Authors:  A K GAYEN
Journal:  Biometrika       Date:  1951-06       Impact factor: 2.445

5.  Haemophilia Bm: a new type of factor-IX deficiency.

Authors:  C Hougie; J J Twomey
Journal:  Lancet       Date:  1967-04-01       Impact factor: 79.321

Review 6.  Genetics of human blood coagulation.

Authors:  C B Kerr
Journal:  J Med Genet       Date:  1965-12       Impact factor: 6.318

7.  Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.

Authors:  D P Stites; E J Hershgold; J D Perlman; H H Fudenberg
Journal:  Science       Date:  1971-01-15       Impact factor: 47.728

8.  Hemophilia A: polymorphism detectable by a factor 8 antibody.

Authors:  D Feinstein; M N Chong; C K Kasper; S I Rapaport
Journal:  Science       Date:  1969-03-07       Impact factor: 47.728

9.  Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.

Authors:  H R Roberts; J E Grizzle; W D McLester; G D Penick
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808
View more
  5 in total

1.  Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype.

Authors:  K K Namboodiri; R C Elston; C J Glueck; R Fallat; C R Buncher; R Tsang
Journal:  Am J Hum Genet       Date:  1975-07       Impact factor: 11.025

2.  Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.

Authors:  K J Smith
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level.

Authors:  K H Orstavik; P Magnus; H Reisner; K Berg; J B Graham; W Nance
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

4.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  Major gene analysis of quantitative variation in blood clotting factor X levels.

Authors:  R M Siervogel; R C Elston; R H Lester; J B Graham
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.